市場は2023年から2028年に18億4,179万米ドル、予測期間中のCAGRは11.66%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、いくつかの慢性疾患の有病率の上昇、創薬および毒性スクリーニング用途におけるiPS細胞の採用の増加、個別化医薬品のためのiPS細胞の需要の高まりによって牽引されています。
本調査では、今後数年間の人工多能性幹細胞（iPS細胞）生産市場の成長を牽引する主な要因の一つとして、細胞初期化技術の進歩を挙げています。また、人工多能性幹細胞バンクや貯蔵の出現、再生医療における人工多能性幹細胞の用途拡大も、市場の大きな需要につながると思われます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global induced pluripotent stem cells production market 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Product Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by End-user
6.1 Market segments
6.2 Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
6.4 Research institutes - Market size and forecast 2023-2028
6.5 Biotechnology companies - Market size and forecast 2023-2028
6.6 Others - Market size and forecast 2023-2028
6.7 Market opportunity by End-user
7 Market Segmentation by Product
7.1 Market segments
7.2 Comparison by Product
7.3 Consumable and kits - Market size and forecast 2023-2028
7.4 Instrument - Market size and forecast 2023-2028
7.5 Services and others - Market size and forecast 2023-2028
7.6 Market opportunity by Product
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 Germany - Market size and forecast 2023-2028
9.11 Canada - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Allele Biotechnology and Pharmaceuticals Inc.
12.4 Applied Biological Materials Inc.
12.5 Applied StemCell
12.6 ATCC
12.7 Axol Biosciences Ltd.
12.8 Cynata Therapeutics Ltd.
12.9 Evotec SE
12.10 Fate Therapeutics Inc.
12.11 FUJIFILM Corp.
12.12 Hitachi Ltd.
12.13 LIFE and BRAIN GmbH
12.14 Lonza Group Ltd.
12.15 Ncardia Services B.V.
12.16 REPROCELL Inc.
12.17 Takara Bio Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global induced pluripotent stem cells production market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by End-user ($ million)
Exhibits51: Data Table on Market opportunity by End-user ($ million)
Exhibits52: Chart on Product - Market share 2023-2028 (%)
Exhibits53: Data Table on Product - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Consumable and kits - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Consumable and kits - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Consumable and kits - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Instrument - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Instrument - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Instrument - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Services and others - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Services and others - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Services and others - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Product ($ million)
Exhibits69: Data Table on Market opportunity by Product ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Allele Biotechnology and Pharmaceuticals Inc. - Overview
Exhibits120: Allele Biotechnology and Pharmaceuticals Inc. - Product / Service
Exhibits121: Allele Biotechnology and Pharmaceuticals Inc. - Key offerings
Exhibits122: Applied Biological Materials Inc. - Overview
Exhibits123: Applied Biological Materials Inc. - Product / Service
Exhibits124: Applied Biological Materials Inc. - Key offerings
Exhibits125: Applied StemCell - Overview
Exhibits126: Applied StemCell - Product / Service
Exhibits127: Applied StemCell - Key offerings
Exhibits128: ATCC - Overview
Exhibits129: ATCC - Product / Service
Exhibits130: ATCC - Key offerings
Exhibits131: Axol Biosciences Ltd. - Overview
Exhibits132: Axol Biosciences Ltd. - Product / Service
Exhibits133: Axol Biosciences Ltd. - Key offerings
Exhibits134: Cynata Therapeutics Ltd. - Overview
Exhibits135: Cynata Therapeutics Ltd. - Product / Service
Exhibits136: Cynata Therapeutics Ltd. - Key offerings
Exhibits137: Evotec SE - Overview
Exhibits138: Evotec SE - Business segments
Exhibits139: Evotec SE - Key offerings
Exhibits140: Evotec SE - Segment focus
Exhibits141: Fate Therapeutics Inc. - Overview
Exhibits142: Fate Therapeutics Inc. - Product / Service
Exhibits143: Fate Therapeutics Inc. - Key offerings
Exhibits144: FUJIFILM Corp. - Overview
Exhibits145: FUJIFILM Corp. - Business segments
Exhibits146: FUJIFILM Corp. - Key news
Exhibits147: FUJIFILM Corp. - Key offerings
Exhibits148: FUJIFILM Corp. - Segment focus
Exhibits149: Hitachi Ltd. - Overview
Exhibits150: Hitachi Ltd. - Business segments
Exhibits151: Hitachi Ltd. - Key news
Exhibits152: Hitachi Ltd. - Key offerings
Exhibits153: Hitachi Ltd. - Segment focus
Exhibits154: LIFE and BRAIN GmbH - Overview
Exhibits155: LIFE and BRAIN GmbH - Product / Service
Exhibits156: LIFE and BRAIN GmbH - Key offerings
Exhibits157: Lonza Group Ltd. - Overview
Exhibits158: Lonza Group Ltd. - Business segments
Exhibits159: Lonza Group Ltd. - Key news
Exhibits160: Lonza Group Ltd. - Key offerings
Exhibits161: Lonza Group Ltd. - Segment focus
Exhibits162: Ncardia Services B.V. - Overview
Exhibits163: Ncardia Services B.V. - Product / Service
Exhibits164: Ncardia Services B.V. - Key offerings
Exhibits165: REPROCELL Inc. - Overview
Exhibits166: REPROCELL Inc. - Product / Service
Exhibits167: REPROCELL Inc. - Key offerings
Exhibits168: Takara Bio Inc. - Overview
Exhibits169: Takara Bio Inc. - Product / Service
Exhibits170: Takara Bio Inc. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations
